NEW YORK, July 25, 2017 -- Stull, Stull & Brody ("SS&B") announces that a shareholder derivative lawsuit was commenced in the United States District Court for the Eastern District of Pennsylvania against officers and directors of Walter Investment Management Corp. (NYSE:WAC) (“Walter Investment” or the “Company”). If you own the common stock of Walter Investment you may contact Stull, Stull & Brody to discuss your rights.
The shareholder complaint alleges that certain of the Company’s officers and directors breached their fiduciary duties and were unjustly enriched between May 3, 2016 and at least June 22, 2017, and caused substantial harm to the Company. The complaint also alleges that defendants issued false and/or misleading statements and/or failed to disclose that: (a) the Company was involved in fraudulent practices that violated the False Claims Act; (b) the Company’s Ditech subsidiary had a material weakness in its internal controls over financial reporting; and (c) the Company lacked adequate internal controls over financial reporting.
If you have any questions concerning this notice or your rights or interests with respect to these matters, you may contact Stull, Stull & Brody, Attn: Jason D’Agnenica, Esq., at [email protected], or by telephone at 1-212-687-7230 x145.
SS&B has litigated class actions for violations of securities laws and breaches of fiduciary duty on behalf of defrauded investors over the past 40 years and has obtained court approval of substantial settlements on numerous occasions. SS&B has offices in New York and Beverly Hills. SS&B’s website (www.ssbny.com) has additional information about the firm.
Attorney advertising. Prior results do not guarantee a similar outcome. This press release may be considered Attorney advertising in some jurisdictions under applicable laws and ethical rules.


OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Washington Post Publisher Will Lewis Steps Down After Layoffs
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Instagram Outage Disrupts Thousands of U.S. Users
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 



